Evan Bailey, MD has served as Chief Medical Officer of Applied Therapeutics since June 2025. Dr. Bailey joined Applied in May 2021 and has previously held the roles of Executive Medical Director and Senior Vice President, Clinical Development. Prior to joining the Company, Dr. Bailey served as Medical Director at Vertex Pharmaceuticals, Inc. (Vertex), where he led the US launch of the prescription drug TRIKAFTA^® for the treatment of Cystic Fibrosis (CF) in 2019, then serving as the Global Medical Lead for CF Pipeline and as a CF disease expert. Prior to that, he served as an Assistant Professor of Pediatrics at the University of Massachusetts Medical School, where he was a practicing pediatric pulmonologist and principal investigator for multiple clinical trials running both the CF clinical and research programs. Dr. Bailey completed his residency in Pediatrics and fellowship in Pediatric Pulmonology at Boston Children’s Hospital. He obtained his MD from Loyola University Chicago Stritch School of Medicine, an MA in Medical Sciences from the Boston University School of Medicine and a BS in Chemistry and French from Boston College.